The drug indicated for parasitic infections was taken at the first symptom of the disease by 27% worldwide; research has already shown that the drug is not suitable for tackling the new coronavirus
RIO – Ineffective in the treatment of COVID-19 and contraindicated by health authorities, the ivermectin it was used by 79.5% of Brazilians who had symptoms of the disease. The information is part of a survey conducted by the Global Health Institute of Barcelona (ISGlobal), which analyzed data from 23 countries, including Brazil, which represent more than 60% of the world’s population. The work was published in the scientific journal Nature.
Globally, 27% of people said they took ivermectin at the first symptom of the disease. Major health agencies around the world advise against the use of the drug in the treatment of covid-19. Several scientific studies have already shown that the medicine, indicated in case of parasitic infections, is ineffective against the disease.
“More efforts are needed to discourage the use of ivermectin and other drugs without proven efficacy and potential toxic effects,” wrote ISGlobal’s Health Systems Research Group Leader Jeffrey V. Lazarus, lead author of the survey.
The work also revealed that 40% of people surveyed said they pay less attention to new information about the pandemic. In all, between 29 June and 10 July 2022, 23,000 people were heard (a thousand in each country); all over the age of 18.
Work has been carried out in South Africa, Germany, Brazil, Canada, Singapore, China, South Korea, Ecuador, Spain, United States, France, Ghana, India, Italy, Kenya, Mexico, Nigeria, Peru, Poland, Russia, Sweden, Turkey and the UK.
+The best content in your email for free. Choose your favorite Terra newsletter. Click here!
Source: Terra
Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.
